← Back to Search

Device

Micro-filament Intracranial Recording for Epilepsy (NeuroSeizure Trial)

N/A

Recruiting

Research Sponsored by McGill University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Clinical diagnosis of refractory epilepsy

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 week after implant

Awards & highlights

NeuroSeizure Trial Summary

This trial uses novel electrodes to record fast ripples in order to improve the identification of the epileptogenic zone and to investigate the neuronal circuits associated with epilepsy.

Who is the study for?

This trial is for individuals with refractory epilepsy who are eligible for a special brain monitoring procedure called sEEG. It's not suitable for those with severe psychiatric issues, intense agitation during seizures, or conditions that prevent MRI scans like claustrophobia or certain implants.Check my eligibility

What is being tested?

The study is testing new intracranial electrodes with micro-tetrodes to record 'fast ripples' in the brain. This could help better identify the epileptogenic zone and understand the neuronal circuits in epilepsy.See study design

What are the potential side effects?

While specific side effects aren't listed, typical risks may include discomfort at electrode sites, potential infection risk from invasive procedures, and general complications related to sEEG monitoring.

NeuroSeizure Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My epilepsy does not improve with treatment.

NeuroSeizure Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 week after implant

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 week after implant

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week after implant for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

evaluate the recording of fast ripples (FRs) and single neuron activity in the brain with the micro tetrodes

Secondary outcome measures

Efficiency of microelectrodes compared to macroelectrodes

NeuroSeizure Trial Design

1Treatment groups

Experimental Treatment

Group I: micro-macroelectrodesExperimental Treatment1 Intervention

Patients will be implanted with usually the novel intracerebral micro-macroelectrodes (instead of the regular clinical macroelectrodes). The primary and secondary outcomes will then be assessed.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

McGill UniversityLead Sponsor

395 Previous Clinical Trials

999,332 Total Patients Enrolled

Media Library

Macro-micro Tetrodes (Device) Clinical Trial Eligibility Overview. Trial Name: NCT05254730 — N/A

Epilepsy Research Study Groups: micro-macroelectrodes

Epilepsy Clinical Trial 2023: Macro-micro Tetrodes Highlights & Side Effects. Trial Name: NCT05254730 — N/A

Macro-micro Tetrodes (Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05254730 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment window for this research project still open?

"Indeed, the data hosted on clinicaltrials.gov supports that this medical experiment is actively seeking patients. It was initially posted September 11th 2020 and most recently updated February 25th 2022; 45 participants need to be sourced from a single facility for its completion."

Answered by AI

What is the scale of recruitment for this experiment?

"Affirmative. This medical trial, which was initially posted on September 11th 2020 is currently open for recruitment. 45 people are required to participate in the study from 1 location and its information has been recently updated on February 25th 2022 according to clinicaltrials.gov's records."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Using Micro-filaments to Detect "Fast Ripples" and Improve the Identification of the Epileptogenic Zone

2020. "Using Micro-filaments to Detect "Fast Ripples" and Improve the Identification of the Epileptogenic Zone". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05254730.